Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

NCT02500407

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
  • Sansum Medical Clinic, Inc. Santa Barbara, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Yale University School Of Medicine New Haven, Connecticut, United States
View all 35 locations
View Trial Details
Completed

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

NCT04772989

Conditions
Advanced Solid Tumor, Blood Protein Disorders, Bronchial Neoplasms, +62 more
Locations
  • UCLA Department of Medicine - Hematology/Oncology Los Angeles, California, United States
  • Mayo Clinic Jacksonville - PPDS Jacksonville, Florida, United States
  • Goshen Health System Goshen, Indiana, United States
  • Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View all 22 locations
View Trial Details
Completed

Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

NCT00278408

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +21 more
Locations
  • Rigshospitalet, Department of Hematology Copenhagen, Denmark
  • Amtssygehuset i Herlev Herlev, Denmark
  • GMP Tummes/Weinberg Aachen, Germany
  • Klinikum St. Marien Amberg, Germany
View all 152 locations
View Trial Details
Completed

A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)

NCT02998476

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Arizona Oncology Associates, PC - HAL Tempe, Arizona, United States
  • Sutter Gould Medical Foundation Modesto, California, United States
View all 70 locations
View Trial Details
Completed

Study Evaluating Safety and Efficacy of INCB050465 Combined With Bendamustine and Obinutuzumab in Relapsed or Refractory Follicular Lymphoma (CITADEL-102)

NCT03039114

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • University of California, San Diego La Jolla, California, United States
  • University of Kansas Cancer Center Fairway, Kansas, United States
  • Center for Cancer and Blood Disorders (CCBD) - Bethesda Bethesda, Maryland, United States
View all 21 locations
View Trial Details
Completed

A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

NCT04210219

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Arensia Exploratory Medicine Tbilisi, Georgia
  • Arensia Exploratory Medicine Chisinau, Moldova
  • Uniwersyteckie Centrum Kliniczne Gdansk, Poland
View all 15 locations
View Trial Details
Completed

A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

NCT04657224

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations
  • Stony Brook University Medical Center Stony Brook, New York, United States
  • Monash Medical Centre Clayton, Australia
  • Peter MacCallum Cancer Centre Melbourne, Australia
  • Linear Clinical Research Ltd Nedlands, Australia
View all 28 locations
View Trial Details

Related conditions